AU4356299A - Utilization of growth factors for the production of medicaments - Google Patents
Utilization of growth factors for the production of medicamentsInfo
- Publication number
- AU4356299A AU4356299A AU43562/99A AU4356299A AU4356299A AU 4356299 A AU4356299 A AU 4356299A AU 43562/99 A AU43562/99 A AU 43562/99A AU 4356299 A AU4356299 A AU 4356299A AU 4356299 A AU4356299 A AU 4356299A
- Authority
- AU
- Australia
- Prior art keywords
- medicaments
- utilization
- production
- growth factors
- growth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/10—Polypeptides; Proteins
- A61L24/106—Fibrin; Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0019—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
- A61L2300/414—Growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/12—Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH1375/98 | 1998-06-29 | ||
CH137598 | 1998-06-29 | ||
PCT/CH1999/000278 WO2000000180A1 (en) | 1998-06-29 | 1999-06-29 | Utilization of growth factors for the production of medicaments |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4356299A true AU4356299A (en) | 2000-01-17 |
Family
ID=4208961
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU43562/99A Abandoned AU4356299A (en) | 1998-06-29 | 1999-06-29 | Utilization of growth factors for the production of medicaments |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1091730A1 (en) |
JP (1) | JP2002519317A (en) |
AU (1) | AU4356299A (en) |
WO (1) | WO2000000180A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001058426A1 (en) * | 2000-02-09 | 2001-08-16 | White Spot Ag | Sustained release composition comprising insuline like growth factor |
KR100720052B1 (en) | 2005-10-07 | 2007-05-18 | (주) 차바이오텍 | Microsphere or microbead coated with nanoparticle containing growth factor for regenerating cartilaginous tissue |
JP4843797B2 (en) * | 2006-01-18 | 2011-12-21 | 国立大学法人 東京医科歯科大学 | Biomaterial for bone formation containing osteogenesis promoting substance and nanogel |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE252894T1 (en) * | 1995-01-05 | 2003-11-15 | Univ Michigan | SURFACE-MODIFIED NANOPARTICLES AND METHODS FOR THEIR PRODUCTION AND USE |
KR100236771B1 (en) * | 1997-04-01 | 2000-02-01 | 성재갑 | Hyaluronate microparticles for sustained release of drug |
US6214008B1 (en) * | 1997-04-16 | 2001-04-10 | White Spot Ag | Biodegradable osteosynthesis implant |
EP0896825B1 (en) * | 1997-08-14 | 2002-07-17 | Sulzer Innotec Ag | Composition and device for in vivo cartilage repair comprising nanocapsules with osteoinductive and/or chondroinductive factors |
-
1999
- 1999-06-29 WO PCT/CH1999/000278 patent/WO2000000180A1/en not_active Application Discontinuation
- 1999-06-29 JP JP2000556765A patent/JP2002519317A/en active Pending
- 1999-06-29 AU AU43562/99A patent/AU4356299A/en not_active Abandoned
- 1999-06-29 EP EP99926216A patent/EP1091730A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
JP2002519317A (en) | 2002-07-02 |
WO2000000180A1 (en) | 2000-01-06 |
EP1091730A1 (en) | 2001-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4925799A (en) | Production of propylene | |
AU3219000A (en) | Controlling production | |
AU1430699A (en) | Production of propylene | |
AU7653400A (en) | Polyolefin production | |
AU3994299A (en) | Process for preparing 4-aminodiphenylamines | |
AU7466900A (en) | A process for the preparation of h-tyr-d-ala-phe(f)-phe-nh2 | |
AU2484099A (en) | Reactive distillation process for the production of xylenes | |
AU2748799A (en) | Process for the production of a shaped article | |
AU4288900A (en) | Production of polyethylene | |
AU2682200A (en) | Process for the production of olefins | |
AU4902699A (en) | Polyolefin production | |
AU1434301A (en) | Process for the preparation of sulfamides | |
AU4267099A (en) | Production of polyethylene | |
AU4659199A (en) | Process for the preparation of urea | |
AU3330699A (en) | Process for the production of microcapsules | |
AU4774099A (en) | Polyolefin production | |
AU8627798A (en) | Biocatalytic process for the preparation of 3-0-acyl-flavonoids | |
AU4356299A (en) | Utilization of growth factors for the production of medicaments | |
AU7773700A (en) | Method for the production or preparation of 2,6-dichlorotoluol | |
AU2566100A (en) | Process for the production of a nutritional composition | |
AU4137799A (en) | Polyolefin production | |
AU7306100A (en) | A stereoselective process for the preparation of endo-3-aminoazabicycloalkanes | |
AU2829700A (en) | Processes for the preparation of alpha-aminoketones | |
AU5779998A (en) | Process for the preparation of cyanoarylmethylamine | |
AU4010000A (en) | Epimerization reaction for the production of r-fluoxetine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |